Literature DB >> 3498767

Purification and partial sequence analysis of murine B cell growth factor II (interleukin 5).

D T McKenzie1, H I Filutowicz, S L Swain, R W Dutton.   

Abstract

Murine B cell growth factor II (BCGF-II/interleukin 5) was purified from the conditioned media of the helper T cell line D10 . G4 . 1. The purification scheme consisted of sequential batch adsorption onto trimethylsilyl-controlled pore glass beads, high pressure ion exchange chromatography, and reverse phase high pressure liquid chromatography. The purified BCGF-II had a relative molecular weight of 45,000 when analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis under nonreducing conditions. Identical analysis of BCGF-II under reducing conditions yielded a m.w. of 22,500, suggesting that native BCGF-II exists as a homodimer. The NH2-terminal amino acid sequence of the purified lymphokine was determined by automated Edman degradation. A single amino acid sequence of 24 residues was obtained that, upon comparison, was contained within the cDNA pSP6K-mTRF23 recently described as encoding murine BCGF-II/T cell-replacing factor. The NH2-terminal methionine in mature BCGF-II is found at position 21 of the amino acid sequence predicted from the cDNA pSP6K-mTRF23. This finding supports the contention of Kinashi et al. (Kinashi, T., N. Harada, E. Severinson, T. Tanabe, P. Sideras, M. Konishi, C. Azuma, A. Tominaga, S. Bergstedt-Lindqvist, M. Takahashi, F. Matsuda, Y. Yaoita, K. Takatsu, and T. Honjo. 1986. Nature 324:70) that amino acids 1-20 serve as the signal sequence for the BCGF-II gene. The ability of BCGF-II to stimulate the proliferation of the B cell lymphoma BCL1 was used to assess the potency of the lymphokine. BCGF-II at 13.5 pM induced 50% of the maximal proliferative response in the BCL1 cells; concentrations as low as 2 pM were still effective in stimulating the growth of the cells. Assuming that the amount of BCGF-II necessary to mount a 50% response in the BCL1 assay is defined as one unit of activity, then the purified BCGF-II has a specific activity of 16.5 U/ng of protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498767

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Identification of a cDNA for a human high-molecular-weight B-cell growth factor.

Authors:  J L Ambrus; J Pippin; A Joseph; C Xu; D Blumenthal; A Tamayo; K Claypool; D McCourt; A Srikiatchatochorn; R J Ford
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

2.  Preparation and characterization of human interleukin-5 expressed in recombinant Escherichia coli.

Authors:  A E Proudfoot; D Fattah; E H Kawashima; A Bernard; P T Wingfield
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

3.  Interleukin-5 induces maturation but not class switching of surface IgA-positive B cells into IgA-secreting cells.

Authors:  R Matsumoto; M Matsumoto; S Mita; Y Hitoshi; M Ando; S Araki; N Yamaguchi; A Tominaga; K Takatsu
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

4.  Human interleukin-5 expressed in Escherichia coli has N-terminal modifications.

Authors:  K Rose; P O Regamey; R Anderegg; T N Wells; A E Proudfoot
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

5.  Vicia villosa agglutinin separates freshly isolated Peyer's Patch T cells into interleukin 5- or interleukin 2-producing subsets.

Authors:  S Schoenbeck; M J Hammen; M F Kagnoff
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

Review 6.  Targeting eosinophils: severe asthma and beyond.

Authors:  Marco Caminati; Francesco Menzella; Lucia Guidolin; Gianenrico Senna
Journal:  Drugs Context       Date:  2019-07-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.